Moors & Cabot, Inc.
- SEC CIK
- 0001607239
- Latest filing
- Aug 10, 2026
AXSM holding history
Axsome Therapeutics, Inc. in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,330
- Value
- $570.3K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,330 | $570.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 2,330 | $393.8K | <0.1% | −100−4.1% | Reduced | Holders |
| Q4 2025 | 2,430 | $443.8K | <0.1% | +50+2.1% | Added | Holders |
| Q3 2025 | 2,380 | $289.1K | <0.1% | +50+2.1% | Added | Holders |
| Q2 2025 | 2,330 | $243.2K | <0.1% | +100+4.5% | Added | Holders |
| Q1 2025 | 2,230 | $260.1K | <0.1% | +2,230 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −2,230−100.0% | Sold out | Holders |
| Q3 2024 | 2,230 | $200.4K | <0.1% | +2,230 | New | Holders |